Tick (check) box to add article to PDF "basket"
DECIDE stands for 'Diagnostic Enhancement of Confidence by an International Distributed Environment'. This FP7 project brought together 13 partners from five European countries, with the Italian GARR Institute as leading partner. Its aim was to develop and launch an e-service that allows the early diagnosis of Alzheimer's and other neurodegenerative diseases.
Published: 6 June 2014
Stroke is the most common neurological disease. It is also the most common cause of life-long impairment in adulthood and of institutionalisation, implying a change from a self-determined, independent life to extensive or complete dependence on others.
Published: 27 May 2014
While nuclear medicine (specialty involving the application of radioactive substances in the diagnosis and treatment of disease) and interventional radiology may give doctors life-saving technology to diagnose and treat diseases, the radiation emitted from the machines and systems could lead to some risks for the doctors.
Published: 21 May 2014
A range of safety and environmental issues are associated with lithium-ion batteries, including the potential risk of sudden explosions when used in electric vehicles and the disposal of toxic materials. To address these issues, the European Union (EU)-funded SOMABAT project developed innovative strategies for producing lithium-polymer batteries that are cleaner, safer and better performing than conventional lithium-ion batteries.
Published: 26 February 2014
The project team developed the first software-based decision-support tool for the building design and construction sector that offers results and a rating system for specific buildings as well as references to building accessibility requirements.
Published: 28 January 2014
Published: 23 January 2014
Whether we like it or not, chemicals are a major part of life. We accept them as a necessary element of modern existence. But what are the long-term effects of chemical exposure on human health? Is there a point at which we may be exposed to more substances than we can physically tolerate?
Published: 26 November 2013
Preparations are underway for a second phase of the European & Developing Countries Clinical Trials Partnership programme (EDCTP2, 2014-2024), which is expected to start in the course of 2014 as part of the EU's Horizon 2020 research funding programme.
Published: 16 October 2013
One of the fundamental challenges in modern society is the need to decouple environmental impact from economic growth. This is essential not just for fast-growing countries such as China or India, but also for the United States and Europe. Already a leading force in environmental technologies during the last decade, the European Union aims to further increase its competitiveness by promoting research and development on eco-innovation and thereby creating a strategy for sustainable economic growth.
Published: 4 September 2013
A potentially ground-breaking human drug trial is currently underway, which aims to discover whether blood pressure medication can slow or halt the progression of Alzheimers Disease (AD). This is the latest in EU-funded studies, which are being made public to highlight the European Month of the Brain.
Published: 29 May 2013